產(chǎn)品詳情
簡(jiǎn)單介紹：
Anti-AADACL1抗體產(chǎn)品質(zhì)量穩(wěn)定，實(shí)驗(yàn)效果明顯，貨期快，價(jià)格優(yōu)惠，歡迎垂詢訂購！我公司長(zhǎng)期供應(yīng)**組化抗體、WB抗體、**組化試劑盒和抗體試驗(yàn)所需全部相關(guān)試劑、熒光標(biāo)記抗體、單克隆抗體、多克隆抗體、各種標(biāo)記的二抗IgG/IgM/IgD/IgA等科研實(shí)驗(yàn)抗體。Anti-AADACL1抗體用于**組化實(shí)驗(yàn),WB實(shí)驗(yàn),相應(yīng)的標(biāo)記抗體有HRP標(biāo)記抗體,FITC標(biāo)記,BIO等。
詳情介紹：
Rabbit Anti-AADACL1
Cat. Number:
Anti-AADACL1抗體XY-5162R
Quantity size:
0.2ml
Concentration:
1mg/ml Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background:
The assembly of very-low-density lipoproteins (VLDLs) in the secretory apparatus of the hepatocyte relies on the mobilization Anti-AADACL1抗體of triacylglycerol (TAG) from the cytosolic pool by lipolysis and re-esterification. However, some of the re-esterified TAG products are returned to the cytosolic pool in the liver, which protects vulnerable body tissues from excess lipotoxic non-esterified fatty acids in the plasma. Some of the lipases involved in this process include arylacetamide deacetylase (AADAC) and its related proteins AADACL1 and AADACL2. AADAC, a single pass type II membrane protein of the endoplasmic reticulum, is expressed in hepatocytes, intestinal mucosal cells, pancreas and adrenal gland. It plays an important role in the metabolic activation of arylamine substrates to ultimate carcinogens. AADACL1 hydrolyzes the metabolic intermediate 2-acetyl monoalkylglycerol, and its inactivation results in disruption of ether lipid metabolism in cancer cells and impaired cell migration and tumor growth.
Also known as:
Arylacetamide deacetylase Anti-AADACL1抗體like 1; Arylacetamide deacetylase-like 1; Kiaa1363; NCEH; Nceh1; NCEH1_HUMAN; Neutral cholesterol ester hydrolase 1; Neutral cholesterol ester hydrolase.
Specificity:
●
Rabbit Polyclonal IgG, affinity purified by Protein A.
●
Reacts with: Human, Mouse, Rat, .
●
Immunogen: KLH conjugated synthetic peptide derived from human AADACL1.
●
Predicted Molecular Weight: 46kDa.
Storage:
Shipped at 4℃, Store at -20℃ (Avoid repeated freeze/thaw cycles).
Application:
WB=1:100-500 ELISA=1:500-1000Anti-AADACL1抗體 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500
Not yet tested in other applications.
Optimal working dilutions Anti-AADACL1抗體must be determined by the end user.
Not yet tested in other applications.
Optimal working dilutions Anti-AADACL1抗體must be determined by the end user.
xy-6127R Lysyl tRNA synthetase賴氨酸t(yī)RNA的連接酶抗體
xy-7040R Kidins220220kDa蛋白激酶D相互作用蛋白抗體
xy-7041R phospho-Kidins220 (Ser918)磷酸化220kDa蛋白激酶D相互作用蛋白抗體
xy-4642R KRV-VP1 + KRV-VP2 (C-terminus)基爾曼氏細(xì)小病毒VP1/VP2抗體(大鼠潛在病毒KRV)C端
xy-6760R KCNQ1鉀離子通道蛋白家族KCNQ1抗體
xy-5708R KMT1A組蛋白H3 K9甲基轉(zhuǎn)移酶抗體
xy-6346R KAT13D生物鐘KAT13D蛋白抗體
xy-9628R KLHL36Kelch樣蛋白36抗體
xy-12170R KCC4鉀氯離子轉(zhuǎn)運(yùn)蛋白KCC4抗體
xy-12171R phospho-KCNA3(Tyr135)磷酸化離子通道蛋白Kv1.3抗體
xy-12172R KCNE4鉀離子通道蛋白家族成員4抗體
xy-12173R KCNF1電壓門控性鉀通道蛋白亞基kv5.1抗體
xy-12174R KCNG1電壓門控性鉀通道蛋白亞基kv6.1抗體
xy-12175R KCNG3電壓門控性鉀通道蛋白亞基KV6.3抗體
xy-12176R phospho-KCNJ1(Ser44)磷酸化細(xì)胞內(nèi)流鉀通道蛋白KCNJ1抗體
xy-12177R KCNT2鈣激活鉀通道蛋白KCNT2抗體
xy-12179R KIR5.1細(xì)胞內(nèi)流鉀通道蛋白Kir5.1抗體
xy-12180R phospho-KIR5.1(Ser416)磷酸化細(xì)胞內(nèi)流鉀通道蛋白Kir5.1抗體
xy-12181R phospho-Kir6.2(Thr224)磷酸化ATP敏感性鉀通道亞基kir6.2抗體
xy-12182R KCNA2B電壓門控鉀通道蛋白KVβ.2抗體
xy-12183R Kv1.4電壓門控性鉀通道蛋白Kv1.4抗體
xy-12184R Kv1.6電壓門控性鉀通道Kv1.6抗體
xy-12185R phospho-Kv2.1(Ser805)磷酸化鉀通道蛋白DRK1抗體
xy-12186R Kv2.2電壓門控性鉀通道Kv2.2抗體
